NCT00379717View on ClinicalTrials.gov

Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)

PHASE1/PHASE2UnknownINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

November 30, 2006

Study Completion Date

April 30, 2008

Conditions

Non-Small-Cell Lung Carcinoma

Interventions

DRUG

Cisplatinum

DRUG

Docetaxel

DEVICE

Tomotherapy

Trial Locations (1)

1090

RECRUITING

UZ Brussel, Jette

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Sanofi

INDUSTRY

lead

AZ-VUB

OTHER